Diabetes technology

Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of multiple daily injections (MDI) vs continuous subcutaneous insulin infusion (CSII) treatments

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

Pediatric T1D is associated with multimodal neuroimaging alterations influenced by insulin treatment modality.

Study context

Population
Children with T1D and controls16 T1D children
Exposure
MDI vs CSII vs controls
  • MDIn = 8
  • CSIIn = 8
  • Controlsn = eightreference
Outcome
Multimodal MRI features discriminating groups and links to HbA1c and WI repetition
Methodological detailsmultimodal MRI, machine-learning feature selection, mediation analysis
  • Multimodal MRI
  • Machine-learning feature selection
  • Mediation analysis

Main finding

As reported in the abstract

Functional vs structural features, balanced accuracy
0.83 vs 0.67
Right inferior frontal gyrus (IFG) volume correlated with HbA1c
r = 0.71, P < .05
Right IFG volume predicted HbA1c
β = 0.28, P = .015
Higher HbA1c related to poorer WI repetition
r = −0.60, P = .013
Right IFG volume related to poorer WI repetition
r = −0.70, P = .002
Indirect HbA1c effect via right IFG volume (a × b), explaining ∼64% of total association
−0.676; Sobel z = −1.765, one-tailed P = .0388

Observational data: associations, not effects.

Further findings

Mean rank

OutcomeMDICSIIP value
WI repetition mean ranksCSII vs MDI5.8111.19P = 0.023
WI repetition mean ranks — CSII had lower hyperglycemia exposure than MDI
30%

Original publication

Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of MDI vs CSII treatments. J Clin Endocrinol Metab. Published 7 March 2026. doi:10.1210/clinem/dgag102

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.